Nordic Life Science Platform ApS: Financial statements 2024
CVR: 43641115
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Nordic Life Science Platform ApS (CVR 43641115) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 5,648 and a net result of DKK 4,390. Equity in the 2024 report amounted to DKK 19,931. The solvency ratio was 68.7%.
- Gross Profit
- DKK 5,648
- Profit/Loss
- DKK 4,390
- Equity
- DKK 19,931
- Total Assets
- DKK 29,006
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Nordic Life Science Platform ApS has published its interim report for the period November 9, 2022 to December 31, 2023.
As of January 29, 2024, Noam David Stern is registered as adm. dir. of Nordic Life Science Platform ApS.
As of January 29, 2024, Henrik Gunnar Herman has stepped down as adm. dir. of Nordic Life Science Platform ApS.
As of January 29, 2024, Nordic Life Science Platform ApS is registered as an owner of Nordic Life Science Platform ApS with an ownership share of 50%.
As of January 28, 2024, Noam David Stern has stepped down as director of Nordic Life Science Platform ApS.
About Nordic Life Science Platform ApS
Nordic Life Science Platform ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2022. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Nordic Life Science Partners ApS. The management consists of Noam David Stern. The company is owned by Nordic Life Science Platform ApS and Nordics Management International ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -1,637 and a net result of DKK -1,637 compared with DKK 4,390 the year before. Equity in the 2025 report amounted to DKK 25,218.